Jason David Taksey, M.D.
Medical Oncology Physician · Annapolis, MD
Jason David Taksey, M.D. is a medical oncology physician with a practice address in Annapolis, Maryland, and NPI 1316017676, issued on Nov 8, 2006. Check the license (Maryland D0065272, as entered in NPPES) on the Maryland Board of Physicians; the Medicare figures below come from public CMS files.
- Name
- Jason David Taksey
- Credential
- M.D.
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- D0065272 MD
Self-reported in NPPES; status is on the state search - Practice location
- 2003 Medical Pkwy, Annapolis, MD 21401
- Phone
- (410) 573-5300
- Enumerated
- Nov 8, 2006
- Record last updated
- Dec 3, 2013 (not updated in 13 years: call before relying on the address or phone)
- Fax
- (410) 573-5305
- Medicare enrollment
- Enrolled (PECOS I20070221000516); accepts Medicare assignment
- Medical or professional school
- Pennsylvania State University College Of Medicine, 2001
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 2003 Medical Pkwy
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Diana Abell, LPN, IBCLCLactation Consultant (Non-RN)1033654538
- Jeanette Abell, M.D.Hospice and Palliative Medicine (Internal Medicine) Physician1346223906
- Melinda Afzal, DOObstetrics & Gynecology Physician1255586509
- Julie Bache, CNMMidwife1255681110
- Igor Belyansky, MDSurgery Physician1497936934
- Janice Bird, M.D.Obstetrics & Gynecology Physician1982628723
Verify Jason David Taksey in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMaryland Board of Physicians
Search for license D0065272Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
3.6 times the Medicare Part D claims of the average medical oncology physician in 2024
2,515 Medicare Part D claims for 299 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 25% of claims. 190 claims were for opioids.
Most prescribed
- Prednisone134 claims
- Levothyroxine Sodium124 claims
- Abiraterone Acetate116 claims
- Eliquis109 claims
- Oxycodone Hcl94 claims
- Lenalidomide90 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 100 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $818.50
29 payments; by number, the most common kind was food and beverage; the largest payer was Intera Oncology, Inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Maryland Oncology Hematology PAColumbia, MD
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Medical Oncology Physician providers in Maryland
There are 224 medical oncology physician records in Maryland.
Other medical oncology physician records in Maryland
- Jeffrey Abrams, M.DClarksville, MD1598035248
- Richard Ambinder, M.D.Baltimore, MD1528022407
- Amir Ameri, MDBaltimore, MD1164089843
- Valsamo Anagnostou, MD-PHDBaltimore, MD1821314030
- Christina Annunziata, M.D., PH.D.Bethesda, MD1093084139
- Mary Armanios, M.D.Baltimore, MD1588628390
- Deborah Armstrong, M.D.Lutherville, MD1437113255
- Kekule AsgariSilver Spring, MD1568927911
- Nilofer Azad, MDBaltimore, MD1568635712
- Ashraf Badros, M.D.Baltimore, MD1821038241
Common questions
What is Jason David Taksey, M.D.'s NPI number?
Jason David Taksey, M.D.'s National Provider Identifier (NPI) is 1316017676, issued on Nov 8, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Jason David Taksey, M.D. located?
The NPPES record lists a practice address at 2003 Medical Pkwy, Annapolis, MD, 21401. Phone: (410) 573-5300. Providers update this record themselves, so call before visiting.
How can I verify Jason David Taksey, M.D.'s license?
NPPES lists Maryland license number D0065272, as entered by the provider. Search the Maryland Board of Physicians at https://www.mbp.state.md.us/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Jason David Taksey, M.D. prescribe under Medicare Part D?
In 2024, Jason David Taksey, M.D. had 2,515 Medicare Part D claims for 299 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
What is Jason David Taksey, M.D.'s MIPS final score?
The 2023 MIPS final score is 100 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.